IntegriChain delivers the life science industry’s largest and only data and business process platform for therapy commercialization and access. Manufacturers rely on our analytics, applications, managed services and expert advisors to power their operations and harness the value of their channel, patient and payer data.
View all products
To ensure you get the most out of your access and commercialization investment, IntegriChain provides a complete set of professional Advisory and Systems Integration Services designed to further your business and success.
Services overview
IntegriChain provides wide array of resources to help you navigate your journey to market access success.
Resources overview
We help all stakeholders in the life sciences industry drive access. We do this through our relentless focus on unifying all of the critical business functions for therapy commercialization and access – contracts and pricing, gross-to-net, channel, and patient services – unlocking strategic payer, provider, pharmacy and patient access insights for our life sciences customers.
Learn more about our company
Keep in touch with IntegrChain through our news and frequent events.
View all news & events
World-class data science drives analytics and applications all accessible from the IntegriChain ICyte Platform combined with outstanding leading Managed Service offerings
Contracts & Pricing
Patient Access
Channel
Gross-to-Net
Learn more about the ICyte Platform
We are an industry leader in Government Pricing Managed Services, providing all relevant calculations required for the Medicaid, Medicare, PHS, and FSS programs. Our GP services are expertly designed with robust data cleansing and standardization, automated data load process, and comprehensive and auditable control reports covering all price calculation detail.
Learn More
Our Rebate Management Managed Services allow customers to scale their payer analytics and contracting functions to meet today’s complex commercial and government access challenges. Our Rebate Management offering is the industry’s leading provider of claims adjudication, handling all of your needs for your claims payments and rebate processing.
IntegriChain’s Chargeback Management Managed Services offers a full suite of chargeback reconciliation and analytics capabilities across GPO/IDN provider and federal contracts such as 340B and FSS. Our offerings marry expert contract management along with unparalleled chargeback processing, uniquely processing the most comprehensive set of validity checks and delivering operational reporting and wholesaler scorecards to better manage your programs.
In this webinar, we will attempt to demystify the potential impact the proposed rule may have on a participating manufacturer’s business. We will share insights and perspectives from the multitude of discussions we have had with manufacturers since the proposed rule was released and highlight some of the key questions that the proposed rule raises. We will also walk through several “real world” examples of how some of these proposed changes may impact a manufacturer’s business to explore the potential application of the more impactful aspects of the proposed rule. WATCH WEBINAR
Increasingly, pharmaceutical manufacturers are realizing that an effective and efficient market access strategy requires careful and coordination management of contracts, pricing, channel and patient data, patient services and gross-to-net processes. Traditionally, this has been performed by different parts of the organization with limited sharing of data, analytics and insights.
READ PAPER
Our industry-leading GTN Managed Services and SaaS offerings improve your forecast accuracy, GTN modeling, and financial close efficiency. GTN Accruals is configured for all standard line items with robust out-of-the-box accrual methodologies; GTN Forecasts delivers industry-standard forecast methodologies configured for each liability line item, along with reports and dashboards, allowing you to analyze your GTN liabilities with drill-down and roll-up capabilities.More on GTN
CGT companies seeking to maximize success for newly launched therapies understand that Gross-to-Net (GTN) – when done right – can improve patient access to therapies while driving revenues. This webinar focuses on mission-critical GTN activities for cell and gene therapy companies planning for commercial launch. IntegriChain experts Josef Magpantay and Angelina Pigna will present a comprehensive countdown of the key GTN milestones your team must hit as you prepare for launch along with other important processes to maximize success REGISTER FOR THE WEBINAR
This white paper focuses on the Top 10 Gross-to-Net Accounting Practices for Successful Product Launches in the Life Sciences Industry.
With IntegriChain’s Refined Patient Data solution, you can: Get more timely visibility to providers who are struggling with payer restrictions, more accurately measure the impact of patient service programs on patient initiation and adherence and make more informed decisions on patient access investments. IntegriChain’s Refined Patient Data solution utilizes world-class data science and statistical models to monitor, cleanse, and properly map aggregated patient status data, turning a useless mess into actionable data.
More on REFINED PATIENT DATA
IntegriChain’s Specialty Pharmacy Analytics delivers diagnostic patient journey insights by calibrating the datasets associated with a suite of business KPIs and analytics to reflect the uniqueness of your brand’s patient access. Our diagnostic analytics for patient initiation, therapy adherence, field reimbursement, hub services, and patient services go a level deeper to uncover the reasons why your patients are struggling to overcome barriers along the patient journey. More on Specialty Pharmacy Analytics
As the industry pioneer in data aggregation, IntegriChain knows what it takes to pull together troves of data from multiple providers and rapidly make it actionable. Our Patient Data Aggregation solution utilizes our industry leading data science and master data management technology to ensure the accuracy and actionability of patient status data.
More on PATIENT DATA AGGREGATION
In this article published in Pharmaceutical Commerce, IntegriChain subject matter experts Sean McCarthy and Ed Doran take a deep dive into the challenge of patient adherence. READ ARTICLE
The latest ICyte Platform Summer Release is all about data actionability. We’ve now made it easier than ever to provide better, deeper visibility into your data within our single access platform so you can proactively simplify your everyday tasks and spend less time dealing with data quality.
READ BLOG
Successful market access demands having the right pharmaceutical in the right place at the right time, from distribution center (DC) to points of care (POC). Unfortunately, this is much easier said than done. The myriad of wholesalers, pharmacies, and immense scale of transactions make it difficult for most manufacturers to get an accurate, timely line-of-sight into inventory availability issues. Poor inventory insight not only raises the risk of stock-outs but also creates uncertainty and wide variability to sensitive gross-to-net accrual and incentive compensation processes. IntegriChain’s Channel Data Aggregation solution transforms multiple data streams into the highest quality inventory insights.
Manufacturers have few existing measures of the inventory held in retail stores, distribution centers, and third-party returns processors. IntegriChain Inventory Analytics reports 100% of inventory in the retail channel, even in pharmacy stores and distribution centers that do not report their inventories.
Your visibility to downstream inventory issues is directly related to the quality and quantity of data sets being used to manage your channel. Many manufacturers encounter unpleasant “surprises” due to: Missing and/or blinded product data, discrepancies in sell-in or sell-out data and conflicting inventory and returns data. IntegriChain Refined Channel Data provides an end-to-end view of product distribution starting with life sciences supplier distributor inventory, distributor sales, chain distribution centers (DC) inventory, store inventory, returns, and point of sale (POS) demand.
Distribution Contract Management is a single, auditable application for managing all aspects of trade partner agreements. Configurable trade partner scorecard functionality features payment adjudication, custom pay-for-performance metrics, payment roll forward, and top- and bottom-line functionality adjustments. These functions are automated and facilitate standardized contract negotiations with trade partners. Manufacturers can also monitor trade partner purchase orders in real time and make decisions based on channel inventory and order quantity.More on Distribution Contract Management
Join us for this important event were we’ll discuss and analyze the impact of COVID-19 on demand and inventories, including: Wholesale/distributor inventories, downstream inventories, changes in demand pattern and channel mix, swings in customer service levels and omit patterns. In addition, we will focus on specific markets most impacted by the coronavirus including Respiratory, Diabetes, Cardiovascular and AntiViral drugs.
WATCH WEBINAR
Join us for this webinar where we will present the best practices on reaching effective order management to limit a manufacturer’s susceptibility to price speculation and serve as a safeguard against suspicious orders of highly-regulated, controlled drugs.
